CN106916126A - A kind of process for purification of docetaxel - Google Patents

A kind of process for purification of docetaxel Download PDF

Info

Publication number
CN106916126A
CN106916126A CN201510997156.6A CN201510997156A CN106916126A CN 106916126 A CN106916126 A CN 106916126A CN 201510997156 A CN201510997156 A CN 201510997156A CN 106916126 A CN106916126 A CN 106916126A
Authority
CN
China
Prior art keywords
docetaxel
volume ratio
acetic acid
purification
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510997156.6A
Other languages
Chinese (zh)
Inventor
黄道飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fu'an Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co Ltd
Original Assignee
Fu'an Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fu'an Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co Ltd filed Critical Fu'an Pharmaceutical Group Ningbo Tianheng Pharmaceutical Co Ltd
Priority to CN201510997156.6A priority Critical patent/CN106916126A/en
Publication of CN106916126A publication Critical patent/CN106916126A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a kind of process for purification of docetaxel, comprise the following steps:1) docetaxel intermediate is dissolved in glacial acetic acid, adds first alcohol and water, the docetaxel intermediate, the mass volume ratio of glacial acetic acid are 1:5~15, the mass volume ratio of first alcohol and water is 1:10~20, the glacial acetic acid is 2 with the mass volume ratio of methyl alcohol:1~1.5;2) 1 to 2 hours of stirring reaction;3) zinc powder, 2 to 3 hours of stirring reaction are added;4) filter, step 3 is obtained into product and is filtered, obtain the solid for separating out;5) carry out refining for the first time, 6) refine for the second time.The process for purification synthesis step of docetaxel of the invention is simple, and production efficiency is high, and the product purity of acquisition is high.

Description

A kind of process for purification of docetaxel
Technical field
The present invention relates to docetaxel field, a kind of refined side of docetaxel is specifically related to Method.
Background technology
Docetaxel, its chemical name be 2aR- (2a α, 4 β, 4a β, 6 β, 9 α, (α R ', β S '), 11 α, 12 α, 12a α, 12b α)-β -1,1- dimethylethoxy-carbonyl amino-α - Carbonyl benzenpropanoic acid 12b- acetyl oxygen -12- benzoxies -2a, 3,4,4a, 5,6,9,10,11,12,12a, 12b- Ten dihydro -4,6,11- trihydroxies -4a, the 8,13,13- tetramethyl -5- oxo -7,11- methylene -1H- ring last of the ten Heavenly stems Pentaene and 3,4 benzo 1,2-b oxa- fourth ring -9- base esters.It is a kind of conventional medicine, it is existing many Xi Tasai synthetic method complex steps, production efficiency is low.
The content of the invention
(1) technical problem to be solved
In view of the shortcomings of the prior art, the present invention provides a kind of refined side of docetaxel Method.
(2) technical scheme
To reach above-mentioned purpose, the invention provides a kind of process for purification of docetaxel, bag Include following steps:
1) docetaxel intermediate is dissolved in methyl alcohol, the docetaxel intermediate, methyl alcohol Mass volume ratio be 1:10, add the quality of acetic acid, the docetaxel intermediate and acetic acid Volume ratio is 1:3.5;
2) half hour of stirring reaction;
3) zinc powder, 1 hour of stirring reaction are added;
4) filter, step 3 is obtained into solidliquid mixture and is filtered, obtain the west more for separating out He matches crude product;
5) it is refined for the first time:Docetaxel crude product is dissolved with ethyl acetate, petroleum ether is added, Crystallization, filtering, dry docetaxel first time highly finished product, the ethyl acetate and petroleum ether Volume ratio be 1: 10~100;
6) refine for second:With first time highly finished product in lower alcohol dissolving step 5, add Water, crystallization, filtering, dry second highly finished product of docetaxel, the lower alcohol and water Volume ratio is 1: 10~100, and the lower alcohol is any one in ethanol, methyl alcohol, propyl alcohol.
Further, docetaxel intermediate, the mass volume ratio of glacial acetic acid in the step 1 It is 1:8.
Further, the reaction temperature of the step 2 and step 3 is 20 ° to 60 °.
(3) beneficial effect
The process for purification synthesis step of docetaxel of the present invention is simple, and production efficiency is high, acquisition Product purity is high.
Specific embodiment
With reference to embodiment, specific embodiment of the invention is described in further detail. Following examples are used to illustrate the present invention, but are not limited to the scope of the present invention.
A kind of process for purification of docetaxel of the invention, comprises the following steps:
1) docetaxel intermediate is dissolved in methyl alcohol, the docetaxel intermediate, methyl alcohol Mass volume ratio be 1:10, add the quality of acetic acid, the docetaxel intermediate and acetic acid Volume ratio is 1:3.5;
2) half hour of stirring reaction;
3) zinc powder, 1 hour of stirring reaction are added;
4) filter, step 3 is obtained into solidliquid mixture and is filtered, obtain the west more for separating out He matches crude product;
5) it is refined for the first time:Docetaxel crude product is dissolved with ethyl acetate, petroleum ether is added, Crystallization, filtering, dry docetaxel first time highly finished product, the ethyl acetate and petroleum ether Volume ratio be 1: 10~100;
6) refine for second:With first time highly finished product in lower alcohol dissolving step 5, add Water, crystallization, filtering, dry second highly finished product of docetaxel, the lower alcohol and water Volume ratio is 1: 10~100, and the lower alcohol is any one in ethanol, methyl alcohol, propyl alcohol.
In the present embodiment, docetaxel intermediate, the quality of glacial acetic acid in the step 1 Volume ratio is 1:8.
In the present embodiment, the reaction temperature of the step 2 and step 3 is 20 ° to 60 °.
Beneficial effects of the present invention:Synthesis step is simple, and production efficiency is high, and the product of acquisition is pure Degree is high.
The above is only the preferred embodiment of the present invention, it is noted that led for this technology For the those of ordinary skill in domain, on the premise of the technology of the present invention principle is not departed from, can be with Some improvements and modifications are made, these improvements and modifications also should be regarded as protection scope of the present invention.

Claims (3)

1. a kind of process for purification of docetaxel, it is characterised in that comprise the following steps:
1) docetaxel intermediate is dissolved in methyl alcohol, the docetaxel intermediate, methyl alcohol Mass volume ratio be 1:10, add the quality of acetic acid, the docetaxel intermediate and acetic acid Volume ratio is 1:3.5;
2) half hour of stirring reaction;
3) zinc powder, 1 hour of stirring reaction are added;
4) filter, step 3 is obtained into solidliquid mixture and is filtered, obtain the west more for separating out He matches crude product;
5) it is refined for the first time:Docetaxel crude product is dissolved with ethyl acetate, petroleum ether is added, Crystallization, filtering, dry docetaxel first time highly finished product, the ethyl acetate and petroleum ether Volume ratio be 1: 10~100;
6) refine for second:With first time highly finished product in lower alcohol dissolving step 5, add Water, crystallization, filtering, dry second highly finished product of docetaxel, the lower alcohol and water Volume ratio is 1: 10~100, and the lower alcohol is any one in ethanol, methyl alcohol, propyl alcohol.
2. the process for purification of docetaxel as claimed in claim 1, it is characterised in that institute State docetaxel intermediate in step 1, the mass volume ratio of glacial acetic acid is 1:8.
3. the process for purification of docetaxel as claimed in claim 1, it is characterised in that institute The reaction temperature for stating step 2 and step 3 is 20 ° to 60 °.
CN201510997156.6A 2015-12-25 2015-12-25 A kind of process for purification of docetaxel Pending CN106916126A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510997156.6A CN106916126A (en) 2015-12-25 2015-12-25 A kind of process for purification of docetaxel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510997156.6A CN106916126A (en) 2015-12-25 2015-12-25 A kind of process for purification of docetaxel

Publications (1)

Publication Number Publication Date
CN106916126A true CN106916126A (en) 2017-07-04

Family

ID=59455695

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510997156.6A Pending CN106916126A (en) 2015-12-25 2015-12-25 A kind of process for purification of docetaxel

Country Status (1)

Country Link
CN (1) CN106916126A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110305080A (en) * 2019-08-12 2019-10-08 新乡双鹭药业有限公司 A kind of purification process of docetaxel

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110305080A (en) * 2019-08-12 2019-10-08 新乡双鹭药业有限公司 A kind of purification process of docetaxel

Similar Documents

Publication Publication Date Title
CN101092421B (en) New technique for extracting sesamin
EP3747864A1 (en) A method for preparing methyl (z)-3-[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene)-oxindole-6-carboxylate (intedanib, nintedanib)
CN104402877A (en) Preparation method of atropine sulphate
CN104529806A (en) Method for preparing high-purity capsaicin
CN106916126A (en) A kind of process for purification of docetaxel
CN103508984B (en) Method that filter adsorption and enrichment method from Chinese yew extract 10-DAB is continuously soaked
CN103420979A (en) Esomeprazole sodium refining method
CN106892918B (en) A kind of new method preparing Rutaecarpine from evodia rutaecarpa
CN104402895B (en) A kind of purification process of homoharringtonine
CN103232380A (en) Method for preparing pomalidomide key intermediate
CN102993135A (en) Method for purifying orlistat
CN105061428B (en) Method for refining tadalafil
CN106946676B (en) Purification method of high-purity trichloroacetone for preparing folic acid
CN104119282B (en) The decolouring of a kind of Fluoxastrobin and method of purification
WO2016082059A1 (en) Method for extracting artemisinin by aqueous solution ultrasound
CN106916120A (en) A kind of synthetic method of high-purity docetaxel
CN106916129A (en) A kind of synthetic method of docetaxel
CN106916128A (en) A kind of simple synthesis of docetaxel
CN103191579A (en) Method for extracting gamma-linolenic acid in spirulina through supercritical CO2
CN102603757A (en) Method for extracting and separating camptothecin from Nothapodytes pittosporoides (Oliv.) Sleum.
CN102351775B (en) Preparation method of levo-5-hydroxytryptophan
CN101812061B (en) Method for producing tetrahydroberineper from berberine hydrochloride
CN103788106A (en) Method for extracting sesamin by utilizing sesame oil residue
CN108586223A (en) The production technology of purified by crystallisation methyl cyclopentenyl ketone
CN103467491A (en) Method for preparing cephalosporin midbody penicillin sulfoxide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170704

WD01 Invention patent application deemed withdrawn after publication